<bill session="117" type="h" number="1371" updated="2023-03-08T19:58:10Z">
  <state datetime="2021-02-25">REFERRED</state>
  <status>
    <introduced datetime="2021-02-25"/>
  </status>
  <introduced datetime="2021-02-25"/>
  <titles>
    <title type="display">Crush the Virus Act of 2021</title>
    <title type="official" as="introduced">Making supplemental appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes.</title>
    <title type="short" as="introduced">Crush the Virus Act of 2021</title>
  </titles>
  <sponsor bioguide_id="R000585"/>
  <cosponsors/>
  <actions>
    <action datetime="2021-02-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-02-25" state="REFERRED">
      <text>Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-02-25">
      <text>Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSBU" name="House Budget" subcommittee="" activity="Referral"/>
    <committee code="HSAP" name="House Appropriations" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Appropriations"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Centers for Disease Control and Prevention (CDC)"/>
    <term name="Computers and information technology"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Department of Homeland Security"/>
    <term name="Drug therapy"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Executive agency funding and structure"/>
    <term name="Federal Emergency Management Agency (FEMA)"/>
    <term name="Genetics"/>
    <term name="Government information and archives"/>
    <term name="Health care coverage and access"/>
    <term name="Health facilities and institutions"/>
    <term name="Health information and medical records"/>
    <term name="Health personnel"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Immunology and vaccination"/>
    <term name="Indian social and development programs"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Manufacturing"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Mental health"/>
    <term name="Military procurement, research, weapons development"/>
    <term name="Minority health"/>
    <term name="Public contracts and procurement"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
    <term name="Rural conditions and development"/>
    <term name="Strategic materials and reserves"/>
    <term name="U.S. territories and protectorates"/>
    <term name="Worker safety and health"/>
  </subjects>
  <amendments/>
  <summary date="2022-03-30T17:18:32Z" status="Introduced in House">Crush the Virus Act of 2021

This bill provides supplemental appropriations to several federal agencies for activities and equipment to respond to COVID-19.

Specifically, the bill provides appropriations to the Department of Health and Human Services, the Centers for Disease Control and Prevention, and the Federal Emergency Management Agency (FEMA).

The bill provides the appropriations for

 distributing and administering vaccines; researching and developing vaccines, therapeutics, and medical supplies; testing, contact tracing, and mitigation activities; disaster relief; medical supplies and equipment; personal protective equipment; reimbursing health care providers for health care related expenses or lost revenues that are attributable to COVID-19; block grants for community mental health services; and block grants for the prevention and treatment of substance abuse.</summary>
</bill>
